[ad_1] BENGALURU, India, Nov. 30, 2023 /PRNewswire/ — Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the integration of the Viatris’ biosimilars business…
Tag: Biosimilar
Biosimilar Business Roundup for October 2023—Podcast Edition
[ad_1] Biosimilar Business Roundup for October 2023—Podcast Edition The Center for Biosimilars [ad_2] Source link
Boehringer launches 81% discounted biosimilar of AbbVie’s Humira
[ad_1] The logo of German pharmaceutical company Boehringer Ingelheim is seen at its building in Shanghai, China February 1, 2019. REUTERS/Stringer/File Photo Acquire Licensing Rights Oct 2 (Reuters) – Germany’s…
Samsung, Sandoz sign deal to commercialize biosimilar SB17
[ad_1] Samsung Bioepis headquarters in Songdo, Incheon [SAMSUNG BIOEPIS] Samsung Bioepis signed an agreement with Switzerland’s Sandoz for the sales of its Stelara biosimilar drug in the North American…
Japan Biosimilars Business and Investment Opportunities Report 2023: Market Size is Expected to Record a CAGR of 29.2% During 2023-2027 to Reach US$3,203.6 Million by 2027
[ad_1] Dublin, May 05, 2023 (GLOBE NEWSWIRE) — The “Japan Biosimilars Business and Investment Opportunities Databook – Q1 2023 Update” report has been added to ResearchAndMarkets.com’s offering. Japan’s biosimilar market…
Canada Biosimilars Business and Investment Opportunities Databook, 2018-2022 & 2023-2027
[ad_1] Dublin, May 05, 2023 (GLOBE NEWSWIRE) — The “Canada Biosimilars Business and Investment Opportunities Databook – Q1 2023 Update” report has been added to ResearchAndMarkets.com’s offering. Canada’s biosimilar market…
Biosimilar Business Recap: New Ustekinumab Partnership; Similis Bio Biosimilar Programs; Celltrion Japan Launch
[ad_1] In the latest biosimilar business news, Fresenius Kabi announced a global partnership with Formycon for an ustekinumab biosimilar; Similis Bio partners with Novel351K to co-develop 3 biosimilars; and Celltrion…